PIK3CA and breast cancer: PIK3CA mutation induces the continuous Activation of Protein Kinase B (PKB/AKT) through the PI3K/AKT pathway, leading to the growth and transformation of fibroblasts and mammary epithelial cells and inhibiting apoptosis, which is closely related to the occurrence and development of breast cancer (Fig. 8).